News Focus
News Focus
icon url

DewDiligence

11/10/22 3:37 PM

#244483 RE: WorstLuck #244408

Why, IYO, is the Dermatologic and Ophthalmic Drugs Advisory Committee more reluctant to hold an in-person panel than the FDA’s other advisory committees?
icon url

DewDiligence

02/17/23 3:21 PM

#245551 RE: WorstLuck #244408

APLS—FDA approves Syfovre—(pegcetacoplan)—for geographic atrophy (dry AMD):

https://t.co/GBwHiRKUXD

The stock is currently halted.